With EGFR overexpression in lung cancers known to be correlated with poor prognosis (Chen et al., 2014), a significant increase in EGFR transcript levels was seen in the TCGA pan lung cancer (∼1.3 fold) and LUSC (∼1.7 fold) [datasets (Figure 1C)]. This evidence concerns the gene EGFR and lung cancer.